Transparenz hinsichtlich möglicher Virussequenzen im Pfizer-Impfstoff Comirnaty

This procedure is a written question concerning the transparency of the genetic sequences used in the Pfizer-BioNTech COVID-19 vaccine, Comirnaty. It seeks to clarify whether specific virus sequences were present in the vaccine and how this information is disclosed to the public. The inquiry primarily affects public health authorities and the pharmaceutical industry, focusing on the openness of medical data and vaccine composition for citizens.